Bookmark and Share
BioAssay: AID 588531

Confirmatory screen for compounds that inhibit KCNQ2 potassium channels using automated patch clamp

Name: Confirmatory screen for compounds that inhibit KCNQ2 potassium channels using automated patch clamp ..more
 Tested Compounds
 Tested Compounds
 Tested Substances
 Tested Substances
AID: 588531
Data Source: Johns Hopkins Ion Channel Center (JHICC_KCNQ2_Inh_IWS)
Depositor Category: NIH Molecular Libraries Probe Production Network
Deposit Date: 2011-10-17

Data Table ( Complete ):           Active    All
Sequence: potassium voltage-gated channel KQT-like protein 2 [Rattus norvegicus]
Description ..   
Protein Family: KCNQ voltage-gated potassium channel

Gene:KCNQ2     Related Protein 3D Structures     More BioActivity Data..
BioActive Compounds: 273
Depositor Specified Assays
2262Summary of probe development for inhibitors of KCNQ2 potassium channelsummarySummary assay for KCNQ2 inhibitor assays.
Name: Confirmatory screen for compounds that inhibit KCNQ2 potassium channels using automated patch clamp

Data Source: Johns Hopkins Ion Channel Center
BioAssay Type: Confirmatory, Confirmatory Screening, Single Concentration Activity Observed(JHICC_KCNQ2_Inh_IWS)

Source (MLPCN Center Name): Johns Hopkins Ion Channel Center (JHICC)
Center Affiliation: Johns Hopkins University, School of Medicine
Screening Center PI: Min Li, Ph.D.
Assay Provider: Min Li, Ph.D.
Network: Molecular Libraries Probe Production Centers Network (MLPCN)
Grant Proposal Number: 1 R03 DA027716-01
Grant Proposal PI: Min Li, Ph.D., Johns Hopkins University School of Medicine
Assay Implementation: Haibo Yu Ph.D., Kaiping Xu, Shunyou Long M.S, David Meyers Ph.D., Meng Wu Ph.D., Owen McManus Ph.D.
Name: Confirmatory screen for compounds that inhibit KCNQ2 potassium channels using automated patch clamp


Voltage-gated potassium (K) channels are critical for neuronal function in excitable tissues such as brain and heart. They are also found in non-excitable tissues important for other functions such as hormone secretion, oxygen-sensing and immune responses. There are more than 100 genes in the human genome encoding different but homologous potassium channels. Isolation and characterization of bioactive chemical probes could enable pharmacological experiments to study channel function provides tools to analyze structure and function.

The M-type channels are unique voltage-gated and ligand-regulated K+ channels with distinct physiological and pharmacological characteristics. They are activated at a voltages near the threshold for action potential initiation and thus regulate membrane excitability. KCNQ (or also called Kv7) channels, members of Kv channel superfamily, include five members, KCNQ1 to KCNQ5. Among them, homodimers and/or heterodimers of KCNQ2 and KCNQ3 are believed components of the M-current channel. Modulators of KCNQ2 may play important roles regulating neuronal function, and KCNQ2 openers have demonstrated efficacy in treating epilepsy and may have further uses for treating pain and anxiety. In vivo studies have supported a role for KCNQ2 inhibitors as cognition enhancers.

Results of large scale compound screens for M-current modulators have not been reported. Molecular and functional studies have indicated that KCNQ2 is a key molecular component of the M-current. It is therefore feasible to design robust, high-throughput screens specifically targeting KCNQ2 channels.


KCNQ2,inhibitor, blocker, Concentration Response Curve, JHICC, Johns Hopkins, Molecular Libraries Probe Production Centers Network, MLPCN.
Principle of the assay
Patch clamp is gold standard to measure channel activities. The purpose of the assay is to validate the compounds identified as inhibitors in the primary screen (PubChem AID: 2156) and confirmatory assay (PubChem AID: 493025) on the KCNQ2 potassium channel. This assay employs automated patch clamp (Ionworks Quattro) to investigate the current response of KCNQ2-CHO elicited by voltage clamp protocols in the presence or absence of test compounds. Compounds were tested in duplicates at 10 microM.

Protocol for automated patch clamp on KCNQ2-CHO cells with voltage clamp
1.#Cell culture: Cells are routinely cultured in DMEM/F12 medium, supplemented with 10% Fetal Bovine Serum (FBS), 50 IU/ml penicillin, 50 ug/ml streptomycin, and 500 ug/ml G418 by using 150mm dishes.
2.#Split cells once they reach 80% to 90% confluence
2.1.#Aspirate medium from culture, add 10 mL of PBS (without Ca2+ and Mg2+) to wash the cell monolayer.
2.2.#Aspirate the PBS.
2.3.#Add 5 mL of 0.05% Trypsin to the 150mm dish, leave dish undisturbed for 3~5 min at 37 to trypsinize the cells.
2.4.#Add 20 mL of growth medium to neutralize the digestion of Trypsin.
2.5.#Transfer cell suspension to 50 mL falcon tube and spin at 750 rpm for 4 min.
2.6.#Remove supernatant and resuspend cells with 6 ml external solution, spin down at 450 rpm for 4 min.
2.7.#Count the cells, adjust the cell density at 2x10;6 per ml.
3.#Prepare 3x compound plates: test compounds are prepared using external solution;
4.#Prepare Amphotericin B: dissolve 5 mg Amphotericin B with 180 uL DMSO, vortex for 1 min; transfer dissolved amphotericin B to 50 mL internal buffer, fill in the amphotericin B tube.
5.#Fill the external solution in the buffer boat; fill the internal solution in the internal solution bottle.
6.#Add the cells in the cell boat.
7.#Load the protocol: The holding potential is -90 mV. To elicit the currents, cells were stimulated by 2,000 ms depolarizing step from -90 mV to +40 mV. Start the experiments.
8.#Measure the currents at the steady state.
9.#Calculate the percentage of current change for tested compounds with the following formula:
Percentage (%) =100* (Current (post-compound)-Current (pre-compound))/Current (pre-compound)
Percentage (%): Percentage of current inhibition observed after the application of the test compound.
Current (pre-compound): Current recorded before the test compound application
Current (post-compound): Current recorded after the test compound application
10.#Outcome assignment
If the test compound causes inhibition effect on KCNQ2 by more than 50%, the compound is considered to be active.
If the test compound does not cause inhibition effect on KCNQ2 by more than 50%, the compound is designated as inactive.
11.#Score assignment
An inactive test compound is assigned the score of 0.
An active test compound is assigned the score of 100.

12. Internal buffer (40 mM KCl, 100 mM K-Gluconate,1 mM MgCl2, 2 mM CaCl2, 5 mM HEPES, pH 7.25)
13. External buffer (137 mM NaCl, 4 mM KCl, 1.8 mM CaCl2, 1 mM MgCl2, and 10 mM HEPES and 10 mM Glucose, pH 7.4)
Result Definitions
OutcomeThe BioAssay activity outcomeOutcome
ScoreThe BioAssay activity ranking scoreInteger
1Percentage (10μM**)Percentage (%) of current inhibition observed after the application of the test compound @+40mVFloat

** Test Concentration.
Additional Information
Grant Number: 1 R03 DA027716-01

Data Table (Concise)